Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis.

Our data indicated that miRNA expression profiles were significantly differentiated between the icteric and anicteric groups. Serum miR-601 and miR-630 at presentation could potentially serve as promising biomarkers for predicting subsequent acute liver failure and overall survival in patients with leptospirosis.